{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/039b783b-a527-4fdf-b3ce-b3c255ad3034/69bc9cdb1a160b44db75c299?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"London TB drug target breakthrough, UK Fusion Strategy 2026, Crimson Desert launches, CS2 reload overhaul, New Sonos Speakers","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61ba036a1a8cbef5973cf0c0/1773968140481-767d8357-c2cf-4209-ad16-c949a6ec00ce.jpeg?height=200","description":"<p>Al’s on with a London health story that actually matters: Imperial and LSHTM flag a promising new target in the fight against drug-resistant TB. Then the government drops its Fusion Strategy 2026 — the long bet on “sun in a box” energy and the jobs that come with it. After that, a quick science detour into why static electricity is still weirdly mysterious. And then it’s a bigger gaming block: <em>Crimson Desert</em> arrives with big early impressions, <em>Counter-Strike 2</em> rewires reloading after decades, Ubisoft reportedly pulls game dev away from Red Storm, and Xbox finally tests the “please let me turn off Quick Resume for this one game” feature. For more on all of it, head to <strong>standard.co.uk</strong> — and follow <strong>Tech and Science Daily from The Standard</strong> for your weekday briefing.</p>","author_name":"The Evening Standard"}